Piezo1 as a mechanical checkpoint in T cell immunotherapy for solid tumors

Area of Science:

• Immunology
• Cancer Biology
• Biophysics

Background:

• Solid tumors resist T cell immunotherapies due to the immunosuppressive tumor microenvironment (TME).
• The mechanosensitive ion channel Piezo1 is a key sensor within the TME, but its precise role in T cell-mediated anti-tumor immunity requires further clarification.

Purpose of the Study:

• To review Piezo1's regulation of T cell functions (activation, proliferation, infiltration) and its impact on solid tumor immunotherapy.
• To synthesize current evidence on Piezo1's dual role in T cell-mediated anti-tumor responses.

Main Methods:

• Literature review synthesizing preclinical and clinical evidence on Piezo1 in T cell immunity and solid tumors.
• Analysis of Piezo1's acute vs. chronic stimulation effects on T cell effector functions and exhaustion.

Main Results:

• Acute Piezo1 activation enhances T cell effector functions and cytotoxicity.
• Chronic Piezo1 stimulation in the stiff TME promotes T cell exhaustion.
• Modulating Piezo1 signaling, especially with matrix normalization, synergistically improves T cell infiltration, persistence, and anti-tumor efficacy.

Conclusions:

• Piezo1 represents a potential mechanical checkpoint for enhancing T cell therapies against solid tumors.
• Clinical translation faces challenges including signal heterogeneity and Piezo1's pleiotropic effects.
• Future research should focus on T cell-specific mechanotherapies, novel targets, and mechanical biomarkers for patient stratification.